New Triple Therapy for Chronic Hepatitis C: Real Life Clinical Experience in a Community Setting

Recent advances in treatment of chronic hepatitis C virus have improved significantly due to the introduction of two new protease inhibitors—telaprevir and boceprevir. In combination with the previous standard of care, peginterferon and ribavirin, telaprevir and boceprevir have demonstrated improved...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Akiyama, Matthew J, Piotrowski, Joy I, Roytman, Marina M, Chan, Siu MA, Hong, Leena K, Huddleston, Leslie, Trujillo, Ruby, Tsai, Naoky CS
Formato: Artigo
Lenguaje:Inglês
Publicado: University Clinical, Education & Research Associate (UCERA) 2013
Materias:
American College of Physicians, Hawai‘i Chapter; Annual Meeting 2013
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3764547/
https://ncbi.nlm.nih.gov/pubmed/24052911
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares